STAT3 and neoplasm: Irrespective of the prevailing combinations of mutations in KPP or KPT mice, we discover a gatekeeper role for tumor-cell-intrinsic STAT3 signaling that provides attractive therapeutic targets, including interference with the activity of upstream cytokines.